MAZE
Maze Therapeutics
$28.69
+$1.01 (+3.65%)Jul 27, 2026
Key metrics
The numbers that frame MAZE today
- Market cap
- $1.59B
- P/E (TTM)
- -13.0
- EV / FCF
- -11.9
- Gross margin
- 100%
- EV / Sales
- 72.5
- ROIC
- -78.9%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $12.81
- 52wk High
- $53.65
Growth
Revenue and earnings trend for MAZE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MAZE
Is Maze Therapeutics a good buy?
No. Maze Therapeutics has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Maze Therapeutics is selling at a very high price.
What is the market capitalization of MAZE?
Maze Therapeutics's market capitalization is $1.59B.
What is the P/E ratio for MAZE stock?
Maze Therapeutics's current P/E ratio is -13.
What is the 52-week high for MAZE stock?
The 52-week high for Maze Therapeutics is $53.65. The current close of $28.69 is 46.5% below that high.
What is the 52-week low for MAZE stock?
The 52-week low for Maze Therapeutics is $12.81. The current close of $28.69 is 124% above that low.
Does MAZE stock pay dividends?
Maze Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MAZE?
Maze Therapeutics's Debt / Equity ratio is 0.18.